Generics

Racemic substitutions for single-enantiomer drugs offer new opportunities for savings.

New changes are making it more difficult for generics and biosimilars to compete on formularies.

First generic specialty injections approved for Novadoz Pharmaceuticals. 

Distributed by Invagen, a subsidiary of Cipla Ltd.

Update: now available from three manufacturers. 

Xellia Pharmaceuticals will manufacture essential antibiotics for Civica Rx.

Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.

FDA granted final approval to drug originally tentatively approved in 2018.

 The average price of generics is about one-eighteenth the price of the brand product.

Eli Lilly creates generic Humalog priced 50% lower 

Stalled competition hurts consumers and may keep prices higher.

Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.

The annual report on generic access and savings shows some impressive numbers for 2017.

An unclear naming system for biosimilars could affect patient safety.

Amazon quietly rolled out a line of OTC products-and that should scare you.

Biosimilar to Herceptin Is Approved and Neulasta biosimilar does well in studies.

Both Pfizer and Teva have brought out generic versions of Viagra, a boon to the millions of men with erectile dysfunction.

A multistate antitrust investigation into generic drug pricing has expanded further.

The FDA is promoting generic competition and issuing new REMS guidance.

A change in reimbursement policy for biosimilar drugs could save CMS billions.

The FDA has issued draft guidances that should ease the way for more generic drugs.

A California bill aimed at curbing drug prices is about to be signed, despite concerns it will raise generic drug prices.

CVS Health executives are pleased that a lawsuit alleging collusion with PBMS on generic drug costs has been withdrawn.

Brand name drug companies are "gaming" the system, according to the FDA head.